Methods for addressing host cell protein impurities in biopharmaceutical product development.
Saved in:
| Title: | Methods for addressing host cell protein impurities in biopharmaceutical product development. |
|---|---|
| Authors: | Tuameh A; National Centre for Macromolecular Hydrodynamics, School of Biosciences, University of Nottingham, Sutton Bonington, UK., Harding SE; National Centre for Macromolecular Hydrodynamics, School of Biosciences, University of Nottingham, Sutton Bonington, UK., Darton NJ; Dosage Form Design and Development, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK. |
| Source: | Biotechnology journal [Biotechnol J] 2023 Mar; Vol. 18 (3), pp. e2200115. Date of Electronic Publication: 2022 Dec 13. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Wiley-VCH Verlag Country of Publication: Germany NLM ID: 101265833 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1860-7314 (Electronic) Linking ISSN: 18606768 NLM ISO Abbreviation: Biotechnol J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36427352 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Methods for addressing host cell protein impurities in biopharmaceutical product development. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tuameh+A%22">Tuameh A</searchLink>; National Centre for Macromolecular Hydrodynamics, School of Biosciences, University of Nottingham, Sutton Bonington, UK.<br /><searchLink fieldCode="AU" term="%22Harding+SE%22">Harding SE</searchLink>; National Centre for Macromolecular Hydrodynamics, School of Biosciences, University of Nottingham, Sutton Bonington, UK.<br /><searchLink fieldCode="AU" term="%22Darton+NJ%22">Darton NJ</searchLink>; Dosage Form Design and Development, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101265833%22">Biotechnology journal</searchLink> [Biotechnol J] 2023 Mar; Vol. 18 (3), pp. e2200115. <i>Date of Electronic Publication: </i>2022 Dec 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-VCH+Verlag%22">Wiley-VCH Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101265833 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1860-7314 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2218606768%22">18606768 </searchLink><i>NLM ISO Abbreviation: </i>Biotechnol J <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36427352 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/biot.202200115 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e2200115 Titles: – TitleFull: Methods for addressing host cell protein impurities in biopharmaceutical product development. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tuameh A – PersonEntity: Name: NameFull: Harding SE – PersonEntity: Name: NameFull: Darton NJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2023 Mar Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1860-7314 Numbering: – Type: volume Value: 18 – Type: issue Value: 3 Titles: – TitleFull: Biotechnology journal Type: main |
| ResultId | 1 |
